AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 66 filers reported holding AQUESTIVE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 16.03 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,725 | -7.3% | 14,853 | 0.0% | 0.00% | – |
| Q2 2023 | $24,507 | +44.7% | 14,853 | 0.0% | 0.00% | – |
| Q1 2023 | $16,932 | +26.4% | 14,853 | 0.0% | 0.00% | – |
| Q4 2022 | $13,399 | -21.2% | 14,853 | 0.0% | 0.00% | – |
| Q3 2022 | $17,000 | +70.0% | 14,853 | 0.0% | 0.00% | – |
| Q2 2022 | $10,000 | -96.7% | 14,853 | -87.0% | 0.00% | – |
| Q1 2022 | $299,000 | -33.0% | 114,623 | 0.0% | 0.00% | – |
| Q4 2021 | $446,000 | -11.2% | 114,623 | -0.4% | 0.00% | – |
| Q3 2021 | $502,000 | +9.4% | 115,043 | -0.6% | 0.00% | – |
| Q2 2021 | $459,000 | -46.3% | 115,723 | -29.5% | 0.00% | – |
| Q1 2021 | $854,000 | +77.2% | 164,259 | +82.5% | 0.00% | – |
| Q4 2020 | $482,000 | +95.1% | 90,019 | +76.8% | 0.00% | – |
| Q3 2020 | $247,000 | -14.2% | 50,926 | -14.1% | 0.00% | – |
| Q2 2020 | $288,000 | +54.8% | 59,268 | +120.7% | 0.00% | – |
| Q1 2019 | $186,000 | +72.2% | 26,849 | +56.8% | 0.00% | – |
| Q4 2018 | $108,000 | – | 17,124 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bratton Capital Management, L.P. | 9,810,958 | $16,188,081 | 100.00% |
| Vahanian & Associates Financial Planning Inc. | 725,208 | $1,196,593 | 3.78% |
| Bracebridge Capital, LLC | 428,571 | $707,142 | 0.39% |
| Latash Investments, LLC | 243,134 | $401,171 | 0.32% |
| XTX Topco Ltd | 138,145 | $227,939 | 0.04% |
| ARMISTICE CAPITAL, LLC | 1,158,000 | $1,910,700 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 84,355 | $139,186 | 0.01% |
| Hillsdale Investment Management Inc. | 66,600 | $109,890 | 0.01% |
| D.B. Root & Company, LLC | 12,950 | $21,368 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 147,856 | $243,962 | 0.01% |